GAIA BioMedicine
Operator of a biopharmaceutical company intended to deliver cancer immuno-cell therapy. The company offers antibody-anchoring peptide technology, tumor infiltration, and off-the-shelf cell formulation...
Valuation
$88.4M
Latest known
Share Price
N/A
Total Raised
$37.6M
Last Round
N/A